Guidewires Market by Product - Global Industry Analysis and Forecast to 2022

Published On : November 2017 Pages : 102 Category: Medical Devices Report Code : HC11317

Industry Outlook and Trend Analysis

The global Guidewires market was worth USD 1.43 billion in the year 2012 and is expected to reach approximately USD 2.51 billion by 2022, while registering itself at a compound annual growth rate (CAGR) of 5.81% during the forecast period. Expanding requirement for minimally invasive intercessions is relied upon to serve the worldwide guidewires market as a high effect rendering driver. Results of various researches recommend that surgeries that are minimally invasive are quickly supplanting open/invasive surgeries. A few points of interest in charge of this move incorporate the existence of higher patient fulfillment levels inferable from lesser entry point wounds and a lesser number of post-surgery complexities and death rates. Likewise, these methods include shorter stays in hospitals and subsequently, are financially more suitable. Increasing worldwide base of aged populace and pervasiveness of appropriate medical conditions, for example, coronary and peripheral occlusions is additionally anticipated that would drive the guidewires showcase amid the conjecture time frame. Cardiovascular diseases have turned into the most predominant reason for mortality and dreariness on the planet amid the most recent 30 years. Rising predominance of ways of life, for example, a developing number of dietary irregularities, rising number of global smokers and increasing incidences of obesity are in charge of the development of cardiovascular disease commonness overall. The treatment of cardiovascular issue has changed drastically because of the advent of new medication treatments and gadgets, for example, stents and guidewires.

Product Outlook and Trend Analysis

The guidewires market in terms of product is divided into four sorts to be specific, urology, neurovascular, peripheral and coronary guidewires. In 2013 Coronary guidewires ruled the general guidewires advertise regarding share by virtue of its high use rates and the existence of vast minimally invasive coronary technique volumes. In 2013 the worldwide normal offering cost for one unit of coronary guidewires was USD 90.2. the cost of products  in the coronary guidewires market are relied upon to decline all through the estimate time frame significantly attributable to the developing number of producer efforts went for checking operational costs and government activities to fortify repayment arrangements. Additionally, makers are endeavoring to create financially savvy items trying to get entrance and increment showcase infiltration rates in developing economies with constrained patient purchasing limits. Costs in North America are relied upon to remain the most elevated all through the figure time frame and are required to remain roughly 20% higher than the worldwide normal selling costs. The second biggest share of the guidewires market was represented by fringe guidewires in 2013 because of the existence of substantial pervasiveness levels of peripheral occlusions.

Regional Outlook and Trend Analysis

Major regional sections of the guidewires market incorporate Asia-Pacific, Europe, North America and RoW. In 2013 The North American guidewires market was the biggest on the basis of revenue. High commonness of neurovascular, cardiovascular disorders, existence of advanced healthcare infrastructure and high patient awareness levels are a few components representing its vast share. Asia-Pacific is distinguished as the quickest developing locale of the guidewires market. The existence of undiscovered opportunities combined with quickly enhancing monetary conditions in developing nations, for example, China and India is relied upon to drive the development of guidewires market in this locale.

Competitive Insights

Some of the leading players in the market are Boston Scientific Corporation, Abbott Laboratories and Terumo Corporation. Terumo Corporation inferable from the existence of a broad item portfolio and high market infiltration rates in rising economies, for example, China and India overwhelmed the peripheral guidewires market in 2013. Major players of the urology guidewires showcase incorporate Boston Scientific Corporation, Terumo Corporation, Cook Medical and Bard Medical Division. Terumo is one of the quickest developing organizations in this fragment with its item "Glidewire" picking up ubiquity among healthcare practitioners. Also, key players of the neurovascular guidewires market incorporate Codman Neurovascular and Asahi Intecc Co., Ltd.

The global Guidewires Market is segmented as follows-

By Product

  • Urology Guidewires
  • Coronary Guidewires
  • Neurovascular Guidewires
  • Peripheral Guidewires

By Region

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others

Some of the key questions answered by the report are:

  • What was the market size in 2012 and forecast from 2013 to 2022?
  • What will be the industry market growth from 2013 to 2022?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

 

  • Guidewires Market, By Product, Estimates and Forecast, 2012-2022 ($Million)
    • Neurovascular Guidewires
    • Peripheral Guidewires
    • Coronary Guidewires
    • Urology Guidewires
  • Guidewires Market, By Region, Estimates and Forecast, 2012-2022 ($Million)
    • North America
  • North America Guidewires Market, By Country
  • North America Guidewires Market, By Product
    • U.S. Guidewires Market, By Product
    • Canada Guidewires Market, By Product
    • Mexico Guidewires Market, By Product
    • Europe
  • Europe Guidewires Market, By Country
  • Europe Guidewires Market, By Product
    • Germany Guidewires Market, By Product
    • France Guidewires Market, By Product
    • UK Guidewires Market, By Product
    • Italy Guidewires Market, By Product
    • Spain Guidewires Market, By Product
    • Rest of Europe Guidewires Market, By Product
    • Asia-Pacific
  • Asia-Pacific Guidewires Market, By Country
  • Asia-Pacific Guidewires Market, By Product
    • Japan Guidewires Market, By Product
    • China Guidewires Market, By Product
    • Australia Guidewires Market, By Product
    • India Guidewires Market, By Product
    • South Korea Guidewires Market, By Product
    • Rest of Asia-Pacific Guidewires Market, By Product
    • Rest of the World
  • Rest of the World Guidewires Market, By Country
  • Rest of the World Guidewires Market, By Product
    • Brazil Guidewires Market, By Product
    • South Africa Guidewires Market, By Product
    • Saudi Arabia Guidewires Market, By Product
    • Turkey Guidewires Market, By Product
    • United Arab Emirates Guidewires Market, By Product
    • Others Guidewires Market, By Product

1.      Introduction

1.1.      Report Description

1.2.      Research Methodology

1.2.1. Secondary Research

1.2.2. Primary Research

2.      Executive Summary

2.1.      Key Highlights

3.      Market Overview

3.1.      Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2.      Market Dynamics

3.2.1. Drivers

3.2.1.1.   Growing aging population base

3.2.1.2.   Minimally invasive surgery demand

3.2.2. Restraints

3.2.2.1.   High cost concern

3.2.3. Opportunities

3.2.3.1.   Development of Advanced Guidewires with Better Integration Capabilities

4.      Guidewires Market, By Product

4.1.      Introduction

4.2.      Guidewires Market Assessment and Forecast, By Product, 2012-2022

4.3.      Neurovascular Guidewires

4.3.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

4.4.      Peripheral Guidewires

4.4.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

4.5.      Coronary Guidewires

4.5.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

4.6.      Urology Guidewires

4.6.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

5.      Guidewires Market, By Region

5.1.      Introduction

5.2.      Guidewires Market Assessment and Forecast, By Region, 2012-2022 ($Million)

5.3.      North America

5.3.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)

5.3.2. Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.3.2.1.   U.S.

5.3.2.1.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.3.2.2.   Canada

5.3.2.2.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.3.2.3.   Mexico

5.3.2.3.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.      Europe

5.4.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)

5.4.2. Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.2.1.   Germany

5.4.2.1.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.2.2.   France

5.4.2.2.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.2.3.   UK

5.4.2.3.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.2.4.   Italy

5.4.2.4.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.2.5.   Spain

5.4.2.5.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.2.6.   Rest of Europe

5.4.2.6.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.      Asia-Pacific

5.5.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)

5.5.2. Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.2.1.   Japan

5.5.2.1.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.2.2.   China

5.5.2.2.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.2.3.   Australia

5.5.2.3.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.2.4.   India

5.5.2.4.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.2.5.   South Korea

5.5.2.5.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.2.6.   Rest of Asia-Pacific

5.5.2.6.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.6.      Rest of the World

5.6.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)

5.6.2. Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.6.2.1.   Brazil

5.6.2.1.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.6.2.2.   Turkey

5.6.2.2.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.6.2.3.   Saudi Arabia

5.6.2.3.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.6.2.4.   South Africa

5.6.2.4.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.6.2.5.   United Arab Emirates

5.6.2.5.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.6.2.6.   Others

5.6.2.6.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

6.      Company Profiles

6.1.      Boston Scientific

6.1.1. Business Overview

6.1.2. Product Portfolio

6.1.3. Key Financials

6.1.4. Strategic Developments

6.2.      Abbott Vascular

6.2.1. Business Overview

6.2.2. Product Portfolio

6.2.3. Key Financials

6.2.4. Strategic Developments

6.3.      Asahi Intecc

6.3.1. Business Overview

6.3.2. Product Portfolio

6.3.3. Key Financials

6.3.4. Strategic Developments

6.4.      AngioDynamic

6.4.1. Business Overview

6.4.2. Product Portfolio

6.4.3. Key Financials

6.4.4. Strategic Developments

6.5.      Cordis Corp.

6.5.1. Business Overview

6.5.2. Product Portfolio

6.5.3. Key Financials

6.5.4. Strategic Developments

6.6.      Covidien

6.6.1. Business Overview

6.6.2. Product Portfolio

6.6.3. Strategic Developments

6.7.      Codman Neurovascular

6.7.1. Business Overview

6.7.2. Product Portfolio

6.7.3. Strategic Developments

6.8.      Cook Medical

6.8.1. Business Overview

6.8.2. Product Portfolio

6.8.3. Key Financials

6.8.4. Strategic Developments

6.9.      Medtronic, Inc

6.9.1. Business Overview

6.9.2. Product Portfolio

6.9.3. Key Financials

6.9.4. Strategic Developments

6.10.   Stryker

6.10.1.    Business Overview

6.10.2.    Product Portfolio

6.10.3.    Key Financials

6.10.4.    Strategic Developments

6.11.   Codman Neurovascular

6.11.1.    Business Overview

6.11.2.    Product Portfolio

6.11.3.    Key Financials

 

6.11.4.    Strategic Developments


List of Tables

Table 1.Guidewires Market, By Product ($Million), 2012-2022
Table 2.Neurovascular Guidewires Market, By Region ($Million), 2012-2022
Table 3.Peripheral Guidewires Market, By Region ($Million), 2012-2022
Table 4.Coronary Guidewires Market, By Region ($Million), 2012-2022
Table 5.Urology Guidewires Market, By Region ($Million), 2012-2022
Table 6.Guidewires Market, By Region ($Million), 2012-2022
Table 7.North America Guidewires Market, By Country, 2012-2022 ($Million)
Table 8.North America Guidewires Market, By Product, 2012-2022 ($Million)
Table 9.U.S. Guidewires Market, By Product, 2012-2022 ($Million)
Table 10.Canada Guidewires Market, By Product, 2012-2022 ($Million)
Table 11.Mexico Guidewires Market, By Product, 2012-2022 ($Million)
Table 12.Europe Guidewires Market, By Country, 2012-2022 ($Million)
Table 13.Europe Guidewires Market, By Product, 2012-2022 ($Million)
Table 14.Germany Guidewires Market, By Product, 2012-2022 ($Million)
Table 15.France Guidewires Market, By Product, 2012-2022 ($Million)
Table 16.UK Guidewires Market, By Product, 2012-2022 ($Million)
Table 17.Italy Guidewires Market, By Product, 2012-2022 ($Million)
Table 18.Spain Guidewires Market, By Product, 2012-2022 ($Million)
Table 19.Rest of Europe Guidewires Market, By Product, 2012-2022 ($Million)
Table 20.Asia-Pacific Guidewires Market, By Country, 2012-2022 ($Million)
Table 21.Asia-Pacific Guidewires Market, By Product, 2012-2022 ($Million)
Table 22.Japan Guidewires Market, By Product, 2012-2022 ($Million)
Table 23.China Guidewires Market, By Product, 2012-2022 ($Million)
Table 24.Australia Guidewires Market, By Product, 2012-2022 ($Million)
Table 25.India Guidewires Market, By Product, 2012-2022 ($Million)
Table 26.South Korea Guidewires Market, By Product, 2012-2022 ($Million)
Table 27.Rest of Asia-Pacific Guidewires Market, By Product, 2012-2022 ($Million)
Table 28.Rest of the World Guidewires Market, By Country, 2012-2022 ($Million)
Table 93.Rest of the World Guidewires Market, By Product, 2012-2022 ($Million)
Table 94.Brazil Guidewires Market, By Product, 2012-2022 ($Million)
Table 95.Turkey Guidewires Market, By Product, 2012-2022 ($Million)
Table 96.Saudi Arabia Guidewires Market, By Product, 2012-2022 ($Million)
Table 97.South Africa Guidewires Market, By Product, 2012-2022 ($Million)
Table 98.United Arab Emirates Guidewires Market, By Product, 2012-2022 ($Million)
Table 99.Others Guidewires Market, By Product, 2012-2022 ($Million)
Table 100.Others Guidewires Market, By Application, 2012-2022 ($Million)
Table 101.Boston Scientific: Key Strategic Developments, 2015-2017
Table 102.Abbott Vascular: Key Strategic Developments, 2015-2017
Table 103.Asahi Intecc: Key Strategic Developments, 2015-2017
Table 104.AngioDynamic: Key Strategic Developments, 2015-2017
Table 105.Cordis Corp.: Key Strategic Developments, 2015-2017
Table 106.Covidien: Key Strategic Developments, 2015-2017
Table 107.Codman Neurovascular: Key Strategic Developments, 2015-2017
Table 108.Cook Medical: Key Strategic Developments, 2015-2017
Table 109.Medtronic, Inc: Key Strategic Developments, 2015-2017
Table 110.Stryker: Key Strategic Developments, 2015-2017
Table 111.Codman Neurovascular: Key Strategic Developments, 2015-2017


List of Figures

Figure 1.Guidewires Market Share, By Product, 2012 & 2022 ($Million)
Figure 4.Guidewires Market, By Region, 2016, ($Million)
Figure 5.Boston Scientific: Net Revenues, 2014-2016 ($Million)
Figure 6.Boston Scientific: Net Revenue Share, By Segment, 2016
Figure 7.Boston Scientific: Net Revenue Share, By Geography, 2016
Figure 8.Cook Medical: Net Revenues, 2014-2016 ($Million)
Figure 9.Cook Medical: Net Revenue Share, By Segment, 2016
Figure 10.Cook Medical: Net Revenue Share, By Geography, 2016
Figure 11.Medtronic, Inc: Net Revenues, 2014-2016 ($Million)
Figure 12.Medtronic, Inc: Net Revenue Share, By Segment, 2016
Figure 13.Medtronic, Inc: Net Revenue Share, By Geography, 2016

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Licesnces Type

For Any Assistance

*
*
*